Showing results (51-60 of 247) with videos related to

Sort By:
Pageof 25
Molecular Cancer Research : MCR|January 17, 2009
Loss-of-function fibroblast growth factor receptor-2 mutations in melanomaMichael G Gartside, Huaibin Chen, Omar A Ibrahimi, et al.
Molecular Cancer|October 9, 2012
Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN statusSara A Byron, David C Loch, Candice L Wellens, et al.
Cell Cycle (Georgetown, Tex.)|August 5, 2008
Low-penetrant RB allele in small-cell cancer shows geldanamycin instability and discordant expression with mutant rasYoonsoo Park, Akihito Kubo, Takefumi Komiya, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 1, 2015
Distinct methylation profiles characterize fusion-positive and fusion-negative rhabdomyosarcomaWenyue Sun, Bishwanath Chatterjee, Yonghong Wang, et al.
The American Journal of Pathology|November 5, 2002
Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiationSusanne V Allander, Peter B Illei, Yidong Chen, et al.
Frontiers in Genetics|July 21, 2015
miR-23a impairs bone differentiation in osteosarcoma via down-regulation of GJA1Yevgeniy Gindin, Yuan Jiang, Princy Francis, et al.
Breast Cancer Research and Treatment|February 13, 2008
TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotypeMonzur Rahman, Sean R Davis, Janet G Pumphrey, et al.
The Journal of Pathology. Clinical Research|July 22, 2022
Spatial expression of the FGFR2b splice isoform and its prognostic significance in endometrioid endometrial carcinomaAsmerom T Sengal, Deborah Smith, Cameron E Snell, et al.
Journal of Cell Science|July 14, 2018
FGFR2-activating mutations disrupt cell polarity to potentiate migration and invasion in endometrial cancer cell modelsSamantha J Stehbens, Robert J Ju, Mark N Adams, et al.
The Journal of Biological Chemistry|October 14, 2011
Cellular settings mediating Src Substrate switching between focal adhesion kinase tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) tyrosine 734Andreas Wortmann, Yaowu He, Melinda E Christensen, et al.
Pageof 25